Related Experiment Video
Updated: Oct 9, 2025
Ex Vivo and In Vivo Animal Models for Mechanical and Chemical Injuries of Corneal Epithelium
Published on: April 6, 2022
Tape Splint Tarsorrhaphy for Persistent Corneal Epithelial Defects
Michael Mimouni1, Eugene S Liu2, Nizar Din2
1From the Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada (M.M., E.S.L., N.D., L.G., S.A., E.C., C.C.C); Department of Ophthalmology, Rambam Health Care Campus affiliated with the Bruce and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel (M.M.).
Tape splint tarsorrhaphy (TST) effectively treated persistent corneal epithelial defects (PCED) in 85.3% of cases. This simple, noninvasive method also significantly improved patient vision.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Vision Science
Background:
- Persistent corneal epithelial defects (PCED) pose a significant challenge in ophthalmology.
- Standard treatments may fail, necessitating alternative interventions.
Purpose of the Study:
- To evaluate the outcomes of tape splint tarsorrhaphy (TST) for managing persistent corneal epithelial defects (PCED).
Main Methods:
- A retrospective, interventional case series design was employed.
- Included were patients with PCEDs unresponsive to bandage contact lenses, treated with TST.
- Key outcome was time to PCED resolution.
Main Results:
- Thirty-four eyes of 33 patients with PCEDs of diverse etiologies were analyzed.
- TST achieved successful resolution in 85.3% of eyes (29/34) within an average of 22.5 days.
- Best-corrected visual acuity significantly improved post-TST (P=.02).
Conclusions:
- Tape splint tarsorrhaphy is a highly effective treatment for persistent corneal epithelial defects.
- The procedure demonstrates a high success rate and visual improvement.
- TST offers a simple, inexpensive, and noninvasive option for PCED management.
